Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,051 | 729 | 99.9% |
| Education | $16.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,139 | 219 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,519 | 85 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,487 | 110 | $0 (2024) |
| Janssen Biotech, Inc. | $713.81 | 36 | $0 (2024) |
| QOL Medical, LLC | $588.51 | 33 | $0 (2024) |
| GENZYME CORPORATION | $367.36 | 18 | $0 (2024) |
| PFIZER INC. | $362.17 | 21 | $0 (2024) |
| Celgene Corporation | $346.90 | 18 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $329.31 | 22 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $311.23 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,666 | 198 | ABBVIE INC. ($1,091) |
| 2023 | $3,440 | 198 | ABBVIE INC. ($1,176) |
| 2022 | $3,600 | 203 | ABBVIE INC. ($985.34) |
| 2021 | $2,362 | 131 | AbbVie Inc. ($886.37) |
All Payment Transactions
730 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GI | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Immunology | ||||||
| 11/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: GI | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 496 | 710 | $358,606 | $50,931 |
| 2022 | 2 | 50 | 51 | $18,243 | $3,791 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 373 | $164,120 | $22,279 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 218 | $130,800 | $19,420 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $21,840 | $3,393 | 15.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 34 | $17,186 | $2,881 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $12,420 | $1,455 | 11.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 20 | $7,200 | $1,127 | 15.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $5,040 | $376.32 | 7.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 38 | $12,311 | $2,558 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $5,932 | $1,233 | 20.8% |
About Daniel Chiu
Daniel Chiu is a Registered Nurse healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2016. The National Provider Identifier (NPI) number assigned to this provider is 1427419530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Chiu has received a total of $13,068 in payments from pharmaceutical and medical device companies, with $3,666 received in 2024. These payments were reported across 730 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($13,051).
As a Medicare-enrolled provider, Chiu has provided services to 546 Medicare beneficiaries, totaling 761 services with total Medicare billing of $54,722. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Gerontology
- Location Orange, CA
- Active Since 03/16/2016
- Last Updated 03/16/2016
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427419530
Products in Payments
- RINVOQ (Biological) $1,562
- ENTYVIO (Biological) $1,042
- XIFAXAN (Drug) $893.73
- SKYRIZI (Biological) $855.38
- HUMIRA (Biological) $810.57
- TRULANCE (Drug) $625.51
- SUCRAID (Drug) $492.34
- DUPIXENT (Biological) $421.44
- LINZESS (Drug) $380.20
- XELJANZ (Drug) $362.17
- ZEPOSIA (Drug) $346.90
- STELARA (Biological) $321.54
- OCALIVA (Drug) $311.23
- REMICADE (Biological) $308.64
- VOWST (Biological) $284.79
- MAVYRET (Drug) $275.62
- IBSRELA (Drug) $273.22
- Linzess (Drug) $262.81
- ZENPEP (Drug) $244.77
- VOQUEZNA (Drug) $234.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Orange
Ms. Kristy Hutputtanasin, Np, NP
Registered Nurse — Payments: $11,751
Jessica Weaver, Np, NP
Registered Nurse — Payments: $5,936
Michael Nicolas, Np, NP
Registered Nurse — Payments: $4,861
Kimberly Gambino, Aprn, Rn, APRN, RN
Registered Nurse — Payments: $4,764
Jonathan Mcintyre, Rn, Crna, RN, CRNA
Registered Nurse — Payments: $2,617
Prof. Amjad Al-Khawaldeh, Phd, Cns, Np, PHD, CNS, NP
Registered Nurse — Payments: $1,872